Skip to Content
  • Previous Rank123
  • Revenues ($M)$22,849.00
  • Revenue Percent Change-0.6%
  • Profits ($M)$1,979.00
  • Profits Percent Change-74.4%
  • Assets ($M)$79,954.00
  • Employees20,800
  • Market Value — as of March 29, 2018 ($M)$122,841.50

The Thousand Oaks, Calif.-based biotech pharmaceutical company makes drugs that treat patients in about 100 countries.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

Robert A. Bradway
CEO Title
Chairman, President & Chief Executive Officer
Health Care
HQ Location
Thousand Oaks, Calif.
Years on Fortune 500 List19

Amgen Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$22,849.00-0.6%
Profits ($M)$1,979.00-74.4%
Assets ($M)$79,954.00-
Total Stockholder Equity ($M)$25,241.00-
Market Value — as of March 29, 2018 ($M)$122,841.50-

Profit Ratios

Profit as % of Revenues8.7%
Profits as % of Assets2.5%
Profits as % of Stockholder Equity7.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)2.69
EPS % Change (from 2016)-73.7%
EPS % Change (5 year annual rate)-13.4%
EPS % Change (10 year annual rate)-0.5%

Total Return

Total Return to Investors (2017)22.1%
Total Return to Investors (5 year, annualized)17.6%
Total Return to Investors (10 year, annualized)15.7%